OncoTherapy Science, Inc. And Institute For Antibodies Conclude Licensing Agreement For Anticancer Antibody 
10/19/2005 5:13:12 PM

Tokyo (JCNN) - Onco Therapy Science (OTS) announced on March 31 that the company has entered into a licensing agreement with the Institute for Antibodies (IFA), a Nagoya-based company engaged in researching and developing antigens and antibodies.